Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease

被引:3
作者
Miller, Morgan R. [1 ,2 ]
Lee, Yee Fun [1 ,2 ,3 ]
Kastanenka, Ksenia V. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA 02129 USA
[2] Harvard Med Sch, Charlestown, MA 02129 USA
[3] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; Calcium Hypothesis; GECI; genetically encoded calcium indicators; GREEN FLUORESCENT PROTEINS; A-BETA-PLAQUES; AMYLOID HYPOTHESIS; NEURAL ACTIVITY; IN-VIVO; CA2+; INDICATOR; HOMEOSTASIS; EMISSION; TAU;
D O I
10.1002/alz.13111
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disease with increasing relevance as dementia cases rise. The etiology of AD is widely debated. The Calcium Hypothesisof Alzheimer's disease and brain aging states that the dysfunction of calcium signaling is the final common pathway leading to neurodegeneration. When the Calcium Hypothesis was originally coined, the technology did not exist to test it, but with the advent of Yellow Cameleon 3.6 (YC3.6) we are able to test its validity. METHODS: Here we review use of YC3.6 in studying Alzheimer's disease using mouse models and discuss whether these studies support or refute the Calcium Hypothesis. RESULTS: YC3.6 studies showed that amyloidosis preceded dysfunction in neuronal calcium signaling and changes in synapse structure. This evidence supports the Calcium Hypothesis. DISCUSSION: In vivo YC3.6 studies point to calcium signaling as a promising therapeutic target; however, additional work is necessary to translate these findings to humans.
引用
收藏
页码:4196 / 4203
页数:8
相关论文
共 50 条
  • [31] Astroglial calcium signalling in Alzheimer's disease
    Verkhratsky, Alexei
    Rodriguez-Arellano, J. J.
    Parpura, Vladimir
    Zorec, Robert
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) : 1005 - 1012
  • [32] Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease
    Popugaeva, Elena
    Chernyuk, Daria
    Bezprozvanny, Ilya
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (04) : 344 - 354
  • [33] Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis
    Supnet, Charlene
    Bezprozvanny, Ilya
    CELL CALCIUM, 2011, 50 (03) : 303 - 309
  • [34] Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
    Anshua Ghosh
    Karl Peter Giese
    Molecular Brain, 8
  • [35] Effect of ginkgolide K on calcium channel activity in Alzheimer's disease
    LIU, H. O. N. G. B. I. N.
    LiI, Q. I. N. Y. U. N.
    ZHANG, X. I. A. O. D. A. N.
    Shi, Y. U. N.
    LiI, J. I. N. Y. I.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (06)
  • [36] Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications
    Joshi, Maithili
    Joshi, Siddhi
    Khambete, Mihir
    Degani, Mariam
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (02) : 453 - 468
  • [37] The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
    Hardy, John
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (04) : 1129 - 1134
  • [38] The Vascular-Immune Hypothesis of Alzheimer's Disease
    Mehta, Rashi I.
    Mehta, Rupal I.
    BIOMEDICINES, 2023, 11 (02)
  • [39] Calcium/calmodulin-dependent kinase II and Alzheimer's disease
    Ghosh, Anshua
    Giese, Karl Peter
    MOLECULAR BRAIN, 2015, 8
  • [40] Astroglial Calcium Signaling in Aging and Alzheimer's Disease
    Verkhratsky, Alexei
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2019, 11 (07):